Lansoprazole 83324-0001
Product NDC
83324-0001- Manufacturer
- Chain Drug Marketing Association
- Dosage Form
- Capsule, Delayed Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- April 12, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA202194
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lansoprazole | 15 mg/1 |
Drug Class
Proton Pump Inhibitor [EPC]Inhibition Gastric Acid Secretion [PE]Proton Pump Inhibitor [EPC]
Packaging Options(1)
1 BOTTLE in 1 CARTON (83324-001-14) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE